Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients

Bibliographic Details
Main Authors: Elder, E.L (Author), Gallagher, K.M.E (Author), Hobbs, G.S (Author), How, J. (Author), Katsis, K. (Author), Larson, R.C (Author), Leick, M.B (Author), Liu, Y. (Author), Maus, M.V (Author), Neuberg, D. (Author)
Format: Article
Language:English
Published: Springer Nature 2022
Online Access:View Fulltext in Publisher
LEADER 00787nam a2200241Ia 4500
001 10-1038-s41375-022-01533-0
008 220420s2022 CNT 000 0 und d
020 |a 08876924 (ISSN) 
245 1 0 |a Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients 
260 0 |b Springer Nature  |c 2022 
300 |a 4 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1038/s41375-022-01533-0 
700 1 0 |a Elder, E.L.  |e author 
700 1 0 |a Gallagher, K.M.E.  |e author 
700 1 0 |a Hobbs, G.S.  |e author 
700 1 0 |a How, J.  |e author 
700 1 0 |a Katsis, K.  |e author 
700 1 0 |a Larson, R.C.  |e author 
700 1 0 |a Leick, M.B.  |e author 
700 1 0 |a Liu, Y.  |e author 
700 1 0 |a Maus, M.V.  |e author 
700 1 0 |a Neuberg, D.  |e author 
773 |t Leukemia